GlassScriptPhysician profile
Alice J Waldrop
NPI 1407825805
$1,120.61
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $403 · 2022: $319 · 2023: $154 · 2024: $94.47 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $187.59 | 2021-2023 | |
| Janssen Biotech, INC. | $184.47 | 2024-2025 | Tremfya, Stelara |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| Redhill Biopharma INC. | $116.76 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $115.81 | 2023 | Zeposia |
| Gilead Sciences, INC. | $100.00 | 2022 | |
| Abbvie INC. | $53.59 | 2021 | |
| Phathom Pharmaceuticals, INC. | $43.40 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $43.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.49 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $24.28 | 2021 | |
| Pfizer INC. | $21.56 | 2023 | |
| Qol Medical, LLC | $18.95 | 2021 | |
| Ferring Pharmaceuticals INC. | $18.87 | 2021 | |
| Lilly USA, LLC | $16.60 | 2024 | Omvoh |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $16.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Waldrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.